New Flexi-Cap for clinical trial supplies combines anti-counterfeit protection with reliable binding for transparent containers; Integrated Booklet-Label offers ample space for product info in different languages.
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 65 years, has a new addition to its Flexi-Cap product family: Flexi-Cap for Clinical Trial Supplies (CTS).
Schreiner MediPharm’s Flexi-Cap solutions irreversibly indicate first opening of primary containers, thus preventing illegal filling and reuse of empty containers with counterfeit substances. The new Flexi-Cap for clinical trials adds reliable blinding of transparent containers to this first-opening protection, accomplished through the use of opaque-printed film caps that prevent investigational products from being distinguished from one another.
The new Flexi-Cap for Clinical Trial Supplies consists of a label and two opaque-printed film caps that completely wrap around the container. While one cap encloses a container’s lid and upper portion, the second cap protects its bottom and lower sections. In this way, the solution ensures reliable blinding of transparent containers, combined with irreversible first-opening protection due to a tear strip integrated into the upper cap.
The need for this combination label concept arose from the requirement that product candidates in clinical trials be reliably blinded in order to achieve optimum test results. Since any visual differences between the active drug and the placebo – including variations in color – must not be discernible to trial subjects, labels need to meet special requirements when transparent containers are used. The new Flexi-Cap version also protects clinical trial supplies against tampering, and provides space for extensive product descriptions in diverse languages – a prerequisite for clinical trials to be efficiently and flexibly conducted in an international context.
Applied without heat, the solution is suitable for temperature-sensitive medicines. Flexi-Cap for Clinical Trial Supplies can be adapted to glass containers of various types, shapes and sizes and also protects against glass breakage. Various colors with high opacity may be used for the caps, and the lid of the film cap offers additional space that can be imprinted with codes or used for integration of NFC chips for interactive applications.
“Schreiner MediPharm is proud of the newest member of our Flexi-Cap family, which combines first-opening protection with reliable blinding in a unique fashion,” said Gene Dul, President of Schreiner MediPharm U.S. “This innovation speaks directly to the critical need for investigational products used in clinical trials to be both truly secure and indistinguishable from each other in order to assure successful research studies.”
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 65 years, has developed a new label-cap combination that protects the integrity of original medicine containers, helping to prevent illegal reuse through clear, irreversible first-opening indication.
Schreiner MediPharm and Applied DNA Sciences offer forensic counterfeit-proof feature for pharma labels
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions, now offers a new forensic authentication feature for pharmaceutical labels in cooperation with Applied DNA Sciences. SigNature DNA is a high-security feature based on DNA markers with which pharmaceutical manufacturers can protect products against counterfeiting, and patients against potential health risks.
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions, has collaborated with B. Braun Medical Inc., located in Bethlehem, PA, who recently launched its prefilled syringe of Heparin Sodium Injection, USP utilizing Schreiner MediPharm’s label- integrated Needle-Trap system to the U.S. market.
Combined expertise: Schreiner MediPharm and Edelmann Group develop demo version of a smart packaging solution
Schreiner MediPharm has combined its expertise in innovative specialty labels and integrated solutions with folding box manufacturer Edelmann. The result is a smart medicine packaging solution with diverse digital features.
A novel dosing syringe label by Schreiner MediPharm supports reliable and exact dosing of a medicine for children as part of a clinical trial. The specialty label was developed for the syringe system made by Raumedic. It serves as a visual barrier, protecting the adjustment button and prevents healthcare staff from accidently activating the mechanism too early.
Schreiner MediPharm introduces BitSecure Mobile, a digital counterfeiting detection solution
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 65 years, has introduced BitSecure Mobile, a digital counterfeiting detection solution to help fight illegal trade in counterfeit medicines.
Schreiner MediPharm develops multifunctional covert-hologram seal for tamper protection
Schreiner MediPharm has developed a multifunctional Covert-Hologram Seal that offers reliable first-opening indication and tamper evidence, plus counterfeiting protection. The seal, which features an irreversible, holographic effect, complies with the Falsified Medicines Directive 2011/62/EU that will be enforced from February 2019.
Schreiner MediPharm develops smart blister pack for clinical trial
Schreiner MediPharm has developed a smart blister pack for digital patient compliance monitoring to enhance medication adherence by clinical trial participants. Schreiner MediPharm implemented the smart packaging solution together with the Dutch technology company ECCT (Experts in Communications and Connectivity Technology). Employment of this electronic tool to manage and track processes during clinical trials marks a milestone for the pharmaceutical manufacturer.
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 65 years, working in conjunction with the Dutch technology company ECCT (Experts in Communications & Connectivity Technology), has developed a smart blister pack for a global pharmaceutical corporation to enhance medication adherence by clinical trial participants.
Schreiner MediPharm supports Biotest AG with “Late Stage Customization” service for supply chain agility
Flexible production of functional labels successfully addresses market segmentation. Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 65 years, recently implemented a special Late Stage Customization service in partnership with its customer, Biotest AG. The new process allows for faster production of functional labels on short demand. As a result, Biotest benefits from greater flexibility and is able to respond to market requirements with requisite agility, while Schreiner MediPharm assists its customer in meeting the demands of current segmentation trends in the pharmaceutical industry.
Schreiner MediPharm develops multi-functional labels for SHL Medical Auto Injectors
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 60 years, has developed specialty labels for demo devices of various SHL Medical auto injector models in which safety and patient ease of use are paramount. .
Schreiner Medipharm develops innovative label with self-lifting starter tab for small vials
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 60 years, has introduced a new version of its Pharma-Comb SL (Self-Lifting) label with a special starter tab.
Pharma-Tac Plus Label from Schreiner MediPharm wins first place in North American Tag and Label Manufacturers Institute International Competition
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 60 years, has been recognized with a first place award for its Pharma-Tac Plus hanging label.
- Clara Boerner
- Company News
- Created 08 Jun 2017
- Modified 08 Jun 2017
- Hits 497